Keraplast names Tony Rayner to lead nutraceuticals and personal care

Keraplast appointed Tony Rayner as General Manager for Nutraceuticals & Personal Care on July 23, 2026, in Christchurch, New Zealand. The hire adds a commercial leader with more than 20 years of experience as Keraplast looks to grow its global ingredient business and expand market presence.

Why it matters: - Tony Rayner takes over a business line tied to Keraplast's global growth plans in nutraceuticals and personal care. - The appointment adds an executive with experience in commercial leadership, customer partnerships and market development. - Keraplast said the role will help accelerate commercial success and expand market presence.

What happened: - Keraplast appointed Tony Rayner as General Manager – Nutraceuticals & Personal Care. - The announcement was made July 23, 2026, in Christchurch, New Zealand. - Rayner joins Keraplast after leadership roles at Westland Milk Products, Asahi New Zealand, Bell Tea & Coffee, Heinz Wattie’s and Goodman Fielder. - Rayner most recently led the Ingredients business at Westland Milk Products.

The details: - Rayner has more than two decades of commercial leadership experience across food, dairy, beverage and ingredients sectors. - His background includes growing businesses, developing strategic partnerships and leading high-performing teams. - At Westland Milk Products, Rayner was responsible for growth through strategic customer partnerships and market development initiatives. - In the new role, Rayner will lead the commercial strategy and performance of Keraplast's Nutraceuticals & Personal Care business. - Rayner will work with Keraplast's Executive Leadership Team to drive sustainable growth, strengthen customer relationships and support strategic objectives. - Howard Moore, Keraplast's chief executive officer, said Rayner's commercial experience, understanding of ingredient businesses and customer relationship skills made him a strong fit for the role.

Between the lines: - Keraplast is signaling that the Nutraceuticals & Personal Care unit is a priority growth engine. - The hire suggests Keraplast wants deeper commercial execution, not just product development, as it pushes into more markets. - The company is leaning on experienced industry operators to sharpen customer-facing strategy.

What's next: - Rayner is expected to focus on commercial growth, customer relationships and execution of Keraplast's strategy. - Keraplast said his leadership will be important as the company continues to grow globally. - Keraplast describes itself as a New Zealand biotechnology company developing and manufacturing protein-derived technologies and ingredients for nutraceutical, personal care, healthcare and medical devices. - More information is available on Keraplast's LinkedIn page.